Carlos Yulo

Carlos Yulo

Ask VT AI
View News Summary
  • Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
  • Former House Speaker Nancy Pelosi's unexpected use of a Southern accent during a Harvard lecture sparks controversy, with some questioning its authenticity.
  • Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
  • Former House Speaker Nancy Pelosi's unexpected use of a Southern accent during a Harvard lecture sparks controversy, with some questioning its authenticity.
  • Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Carlos Yulo